Skip to main content
Clinical Trials/TCTR20221111006
TCTR20221111006
Recruiting
Phase 3

A randomized controlled trial of manual compression of external iliac vein to facilitate femoral central line insertion in infants

Suvikrom Law0 sites206 target enrollmentNovember 11, 2022

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pediatric intensive care unit patientsFemoral central venous catheter insertion
Sponsor
Suvikrom Law
Enrollment
206
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2022
End Date
November 25, 2027
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Suvikrom Law

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients admitted to pediatric intensive care unit or neonatal intensive care unit, 2\. Age less than 1 year old, 3\. Postmenstrual age at least 37 weeks, 4\. Physician in charge decides to insert femoral central venous catheter, 5\. Designated operator in this study is available to perform the procedure

Exclusion Criteria

  • 1\. Unstable vital signs or oxygen saturation, 2\. Known iliac or femoral vein thrombosis or occlusion, 3\. Previously enrolled into this study

Outcomes

Primary Outcomes

Not specified

Similar Trials